Home » Japan Explains Registration Process for Drug Substance Master Files
Japan Explains Registration Process for Drug Substance Master Files
February 17, 2009
Continuing a year-old practice of offering English versions of useful documents and guidelines, Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has published information on registering data on pharmaceutical substances in English.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor